HRAS
History
| Entity | Tier | Description |
|---|---|---|
| 2 | relevance in MZL not firmly established | |
| 2 | relevance in DLBCL not firmly established |
Mutation incidence in large patient cohorts (GAMBL reanalysis)
| Entity | source | frequency (%) |
|---|---|---|
| DLBCL | GAMBL genomes | NA |
| DLBCL | Schmitz cohort | 0.21 |
| DLBCL | Reddy cohort | 0.70 |
| DLBCL | Chapuy cohort | 0.43 |
Mutation pattern and selective pressure estimates
| Entity | aSHM | Significant selection | dN/dS (missense) | dN/dS (nonsense) |
|---|---|---|---|---|
| BL | No | No | 0 | 0 |
| DLBCL | No | No | 0 | 0 |
| FL | No | No | 0 | 0 |
[!NOTE] First described in DLBCL in 2017 by Reddy A
View coding variants in ProteinPaint hg19 or hg38
View all variants in GenomePaint hg19 or hg38
## HRAS
Expression
## References 1.
Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E,
Verney A, Hayette S, Desvignes JP, Salgado D, Levy N, Béroud C, Felman
P, Berger F, Magaud JP, Genestier L, Salles G, Traverse-Glehen A. Exome
sequencing identifies recurrent BCOR alterations and the absence of
KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small
B-cell lymphoma. Haematologica. 2017 Oct;102(10):1758–1766. PMCID:
PMC5622860 2. Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop
A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard
P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q,
Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff
JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear
A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E,
Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M,
Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel
R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS.
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell.
2017 Oct;171(2):481-494.e15.


